Dexcom to Present at Cowen 40th Annual Healthcare Conference
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference:
- Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Cowen 40th Annual Healthcare Conference in Boston, MA, on Monday, March 2, 2020, at 3:30 PM (ET). The presentation, which will occur live at the Boston Marriott Copley Place, will be concurrently webcast.
The link to the webcast will be available on the Dexcom IR website at investors.dexcom.com by navigating to “Events and Presentations”.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005766/en/
Dexcom Inc. Stock
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Dexcom Inc..
As a result the target price of 136 € shows a slightly positive potential of 8.4% compared to the current price of 125.46 € for Dexcom Inc..
